Search
for
Sort by
Research 391–420 of 1000+
- Improvement of dermal and transdermal therapies by nanocarrier-based drug delivery
- Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy
- Encapsulation of Curcumin in Polystyrene-Based Nanoparticles—Drug Loading Capacity and Cytotoxicity
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- 3D Printing—A “Touch-Button” Approach to Manufacture Microneedles for Transdermal Drug Delivery
- Application of 3D Bioprinting Technology for Tissue Regeneration, Drug Evaluation, and Drug Delivery
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Methodologies to Evaluate the Hair Follicle-Targeted Drug Delivery Provided by Nanoparticles
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Dual drug co-encapsulation into liposomes and liposome-derived nanosystems for improved synergistic treatment of skin diseases
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Chemical profiles and pharmacological attributes of Apis cerana indica beehives using combined experimental and computer-aided studies
- Dual-drug nanostructured lipid carriers of spironolactone and 2-deoxy-D-ribose for targeted follicular delivery in androgenetic alopecia
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Assessment of adipokines, hormonal profile, lipid profile, and insulin resistance in patients with androgenetic alopecia
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Recent Advances in Drug Development for Hair Loss
- Scalp Bacterial Profile and Antibiotics Susceptibility Pattern in Patients With Primary Cicatricial Alopecia
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes
- Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance
- Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
- Extracellular vesicles released by hair follicle and adipose mesenchymal stromal cells induce comparable neuroprotective and anti-inflammatory effects in primary neuronal and microglial cultures